Key Takeaways
- • DocsApp, a Bengaluru-based telemedicine platform operated by Phasorz Technologies, closed a Series A funding round of $7.2 million led by Bessemer Venture Partners with participation from Japanese investors Techmatrix Corp. and DeNa Networks, plus angel investors Anand Rajaraman and Venky Harinarayanan.
- • The platform connects patients with over 2,000 specialist doctors across domains including dermatology, gynecology, psychiatry, and general medicine, enabling consultations within 30 minutes through chat or voice call after symptom submission and fee payment.
- • Capital will be deployed toward hiring, product development, operational expansion, and physician recruitment to grow the registered doctor network on the platform.
- • Co-founders Satish Kannan and Enbasekar D., both IIT Madras graduates, launched DocsApp in July 2015 after establishing Phasorz Technologies in 2013; the platform also enables users to order medicines and book diagnostic tests online.
- • Bessemer Venture Partners' participation signals institutional confidence in India's telemedicine market and the model of specialist-focused, on-demand medical consultation delivery.
Summary
Phasorz Technologies Pvt. Ltd, operator of the doctor consultation mobile application DocsApp, announced the close of its Series A funding round on December 12, 2017, raising $7.2 million from a consortium of institutional and individual investors. Bessemer Venture Partners led the round, with Japanese venture capital firms Techmatrix Corp. and DeNa Networks participating as co-investors. Angel investors Anand Rajaraman and Venky Harinarayanan, both early Facebook backers, also joined as follow-on investors. Investment bank Masterkey served as the transaction advisor.
The Bengaluru-based startup, founded in 2013 by IIT Madras graduates Satish Kannan and Enbasekar D., launched DocsApp in July 2015. The platform operates a specialist-doctor model, connecting patients with qualified physicians across seven primary medical domains: dermatology, gynecology, sexology, pediatrics, psychiatry, general medicine, and weight management. As of the funding announcement, DocsApp had onboarded more than 2,000 registered doctors. The service model requires users to upload symptom details and diagnostic reports through the mobile application, pay a consultation fee, and receive assignment to a specialist doctor for one-on-one consultation via chat or voice call, typically within 30 minutes. The platform extends beyond consultation to ancillary services including online medicine ordering and diagnostic test booking.
According to Vishal Gupta, managing director at Bessemer Venture Partners, the platform's differentiation lies in its specialist-first approach and efficiency in matching patients to appropriate physicians. The capital infusion will fund hiring, product development, operational expansion, and initiatives to recruit additional doctors to the platform. CEO Satish Kannan framed the funding as enabling the company to "bridge the gap between patients and specialist doctors" by delivering expert, personalized consultations on demand. The participation of both prominent Western venture capital (Bessemer) and Japanese venture investors (Techmatrix, DeNa, Rebright Partners) reflects cross-border institutional interest in India's digital health sector and the viability of telemedicine models focused on specialist access.
The Bengaluru-based startup, founded in 2013 by IIT Madras graduates Satish Kannan and Enbasekar D., launched DocsApp in July 2015. The platform operates a specialist-doctor model, connecting patients with qualified physicians across seven primary medical domains: dermatology, gynecology, sexology, pediatrics, psychiatry, general medicine, and weight management. As of the funding announcement, DocsApp had onboarded more than 2,000 registered doctors. The service model requires users to upload symptom details and diagnostic reports through the mobile application, pay a consultation fee, and receive assignment to a specialist doctor for one-on-one consultation via chat or voice call, typically within 30 minutes. The platform extends beyond consultation to ancillary services including online medicine ordering and diagnostic test booking.
According to Vishal Gupta, managing director at Bessemer Venture Partners, the platform's differentiation lies in its specialist-first approach and efficiency in matching patients to appropriate physicians. The capital infusion will fund hiring, product development, operational expansion, and initiatives to recruit additional doctors to the platform. CEO Satish Kannan framed the funding as enabling the company to "bridge the gap between patients and specialist doctors" by delivering expert, personalized consultations on demand. The participation of both prominent Western venture capital (Bessemer) and Japanese venture investors (Techmatrix, DeNa, Rebright Partners) reflects cross-border institutional interest in India's digital health sector and the viability of telemedicine models focused on specialist access.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.